An Open Trial of Cysteamine Treatment in Schizophrenia

Stopped early · Not applicable

Conditions studied: Schizophrenia, Schizoaffective

In brief

The purpose of this study is to determine the tolerability of the medication cysteamine bitartrate on schizophrenia patients and to evaluate the effect of the medication on the symptoms of schizophrenia.

Key facts

Study ID
NCT01139125
Run by
Augusta University
People needed
3
Starts
2009-09-01
Expected to finish
2012-06-01
Last updated by the study team
2014-11-20

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.